Soya, maize, and sorghum–based ready-to-use therapeutic food with amino acid is as efficacious as the standard milk and peanut paste–based formulation for the treatment of severe acute malnutrition in children: A noninferiority individually randomized controlled efficacy clinical trial in Malawi

American Journal of Clinical Nutrition

Volumn 106, Issue 4, 2017, Pages 1100-1112

  Bahwere, Paluku ^a,b   Akomo, Peter ^c   Mwale, Mwawi ^d   Murakami, Hitoshi ^e   Banda, Chrissy ^a   Kathumba, Sylvester ^d   Banda, Chimwemwe ^d   Jere, Solomon ^d   Sadler, Kate ^a   Collins, Steve ^a,c  

^a VALID INTERNATIONAL   (United Kingdom)

^b UNIVERSITÉ LIBRE DE BRUXELLES   (Belgium)

^c Valid Nutrition   (Ireland)

^d MINISTRY OF HEALTH   (Malawi)

^e AJINOMOTO CO INC   (Japan)

Author keywords

Amino acid; Anemia; Cow milk; Efficacy; Iron deficiency anemia; Ready to use therapeutic food; Severe acute malnutrition; Sorghum; Soya

Indexed keywords

ALPHA1 GLYCOPROTEIN; AMINO ACID; C REACTIVE PROTEIN; HEMOGLOBIN; TRANSFERRIN RECEPTOR; IRON;

ARTICLE; BODY HEIGHT; CHILD; CHILD NUTRITION; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; DAY CARE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FOLLOW UP; HEALTH SURVEY; HUMAN; INTENTION TO TREAT ANALYSIS; IRON DEFICIENCY ANEMIA; IRON STORAGE; LENGTH OF STAY; MAIZE; MAJOR CLINICAL STUDY; MALAWI; MALAWIAN; MALE; MALNUTRITION; MEDICAL HISTORY; MILK; NONHUMAN; NUTRITIONAL STATUS; OUTCOME ASSESSMENT; PATIENT SAFETY; PEANUT; PHLEBOTOMIST; RANDOMIZED CONTROLLED TRIAL; SORGHUM; SOYBEAN; WORLD HEALTH ORGANIZATION; ANIMAL; ARACHIS; BLOOD; COMPARATIVE STUDY; DEFICIENCY; DIET THERAPY; FAST FOOD; FORTIFIED FOOD; INFANT; METABOLISM; PLANT SEED; PRESCHOOL CHILD; TREATMENT OUTCOME;

AMINO ACIDS; ANEMIA, IRON-DEFICIENCY; ANIMALS; ARACHIS; CHILD, PRESCHOOL; FAST FOODS; FEMALE; FOOD, FORTIFIED; HEMOGLOBINS; HUMANS; INFANT; INTENTION TO TREAT ANALYSIS; IRON; MALAWI; MALE; MILK; SEEDS; SEVERE ACUTE MALNUTRITION; SORGHUM; SOYBEANS; TREATMENT OUTCOME; ZEA MAYS;

EID: 85031691778     PISSN: 00029165     EISSN: 19383207     Source Type: Journal    
DOI: 10.3945/ajcn.117.156653     Document Type: Article

References (57)

1. Black RE, Victora CG, Walker SP, Bhutta ZA, Christian P, de Onis M, Ezzati M, Grantham-McGregor S, Katz J, Martorell R, et al.; Maternal and Child Nutrition Study Group. Maternal and child undernutrition and overweight in low-income and middle-income countries. Lancet 2013;382:427–51.
2. Collins S, Dent N, Binns P, Bahwere P, Sadler K, Hallam A. Management of severe acute malnutrition in children. Lancet 2006;368:1992–2000.
3. Briend A, Lacsala R, Prudhon C, Mounier B, Grellety Y, Golden MHN. Ready-to-use therapeutic food for treatment of marasmus. Lancet 1999;353:1767–8.
4. Manary MJ. Local production and provision of ready-to-use therapeutic food (RUTF) spread for the treatment of severe childhood malnutrition. Food Nutr Bull 2006;27(3 Suppl):S83–9.
5. World Health Organization. Management of severe malnutrition: a manual for physicians and other senior health workers. Geneva (Switzerland): WHO; 1999.
6. Collins S, Sadler K, Dent N, Khara T, Guerrero S, Myatt M, Saboya M, Walsh A. Key issues in the success of community-based management of severe malnutrition. Food Nutr Bull 2006;27:S49–82.
7. Diop el HI, Dossou NI, Ndour MM, Briend A, Wade S. Comparison of the efficacy of a solid ready to use food and a liquid milk-based diet for the rehabilitation of severely malnourished children: a randomized trial. Am J Clin Nutr 2003;78:302–7.
8. UNICEF. Ready-to-use therapeutic food for children with severe acute malnutrition [Internet]. 2013. [cited 2017 Feb 20]. Available from: https://www.unicef.org/media/files/Position_Paper_Ready-to-use_therapeutic_food_for_children_with_severe_acute_malnutrition__June_2013.pdf.
9. Komrska J. Increasing access to ready-to-use therapeutic foods (RUTF). Field Exch. 2012;42:46–7.
10. Irena AH, Bahwere P, Owino VO, Diop EI, Bachmann MO, Mbwili-Muleya C, Dibari F, Sadler K, Collins S. Comparison of the effectiveness of a milk-free soy-maize-sorghum-based ready-to-use therapeutic food to standard ready-to-use therapeutic food with 25% milk in nutrition management of severely acutely malnourished Zambian children: an equivalence non-blinded cluster randomised controlled trial. Matern Child Nutr 2015;11:105–19.
11. Bahwere P, Balaluka B, Wells JC, Mbiribindi CN, Sadler K, Akomo P, Dramaix-Wilmet M, Collins S. Cereals and pulse-based ready-to-use therapeutic food as an alternative to the standard milk- and peanut paste-based formulation for treating severe acute malnutrition: a noninferiority, individually randomized controlled efficacy clinical trial. Am J Clin Nutr 2016;103:1145–61.
12. Bahwere P, Banda T, Sadler K, Nyirenda G, Owino V, Shaba B, Dibari F, Collins S. Effectiveness of milk whey protein-based ready-to-use therapeutic food in treatment of severe acute malnutrition in Malawian under-5 children: a randomised, double-blind, controlled non-inferiority clinical trial. Matern Child Nutr 2014;10:436–51.
13. National Statistical Office, ICF International. Malawi Demographic and Health Survey 2015–16: key indicators report [Internet]. 2016. [cited 2017 Jan 20]. Available from: https://dhsprogram.com/pubs/pdf/PR73/PR73.pdf.
14. Nicoll A. Integrated management of childhood illness in resource-poor countries: an initiative from the World Health Organization. Trans R Soc Trop Med Hyg 2000;94:9–11.
15. World Health Organization. Guideline: updates on the management of severe acute malnutrition in infants and children. Geneva (Switzerland): WHO; 2013.
16. World Health Organization. Training course on child growth assessment. Geneva (Switzerland): WHO; 2008.
17. Takehana S, Yoshida H, Ozawa S, Yamazaki J, Shimbo K, Nakayama A, Mizukoshi T, Miyano H. The effects of pre-analysis sample handling on human plasma amino acid concentrations. Clin Chim Acta 2016;455:68–74.
18. Erhardt JG, Estes JE, Pfeiffer CM, Biesalski HK, Craft NE. Combined measurement of ferritin, soluble transferrin receptor, retinol binding protein, and C-reactive protein by an inexpensive, sensitive, and simple sandwich enzyme-linked immunosorbent assay technique. J Nutr 2004;134:3127–32.
19. Cook JD, Flowers CH, Skikne BS. The quantitative assessment of body iron. Blood 2003;101:3359–64.
20. Yang Z, Dewey KG, Lonnerdal B, Hernell O, Chaparro C, Adu-Afarwuah S, McLean ED, Cohen RJ, Domellof M, Allen LH, et al. Comparison of plasma ferritin concentration with the ratio of plasma transferrin receptor to ferritin in estimating body iron stores: results of 4 intervention trials 8. Am J Clin Nutr 2008;87:1892–8.
21. Thurnham DI, Northrop-Clewes CA, Knowles J. The use of adjustment factors to address the impact of inflammation on vitamin A and iron status in humans. J Nutr 2015;145:1137S–43S.
22. Engle-Stone R, Nankap M, Ndjebayi AO, Erhardt JG, Brown KH. Plasma ferritin and soluble transferrin receptor concentrations and body iron stores identify similar risk factors for iron deficiency but result in different estimates of the national prevalence of iron deficiency and iron-deficiency anemia among women and children in Cameroon. J Nutr 2013;143:369–77.
23. World Health Organization, World Food Programme, UNICEF, and UN Standing Committee on Nutrition. Joint statement on the community-based management of severe malnutrition in children [Internet]. 2007. [cited 2017 Jan 20]. Available from: http://www.who.int/nutrition/topics/statement_community_based_man_sev_acute_mal_eng.pdf.
24. Gibson RS, Bailey KB, Gibbs M, Ferguson EL. A review of phytate, iron, zinc, and calcium concentrations in plant-based complementary foods used in low-income countries and implications for bioavailability. Food Nutr Bull 2010;31(2 Suppl):S134–46.
25. Hurrell RF. Influence of vegetable protein sources on trace element and mineral bioavailability. J Nutr 2003;133:2973S–7S.
26. Abizari AR, Moretti D, Schuth S, Zimmermann MB, Armar-Klemesu M, Brouwer ID. Phytic acid-to-iron molar ratio rather than polyphenol concentration determines iron bioavailability in whole-cowpea meal among young women. J Nutr 2012;142:1950–5.
27. Afify Ael-M, El-Beltagi HS, El-Salam SM, Omran AA. Bioavailability of iron, zinc, phytate and phytase activity during soaking and germination of white sorghum varieties. PLoS One 2011;6:e25512.
28. Greffeuille V, Polycarpe Kayode AP, Icard-Verniere C, Gnimadi M, Rochette I, Mouquet-Rivier C. Changes in iron, zinc and chelating agents during traditional African processing of maize: effect of iron contamination on bioaccessibility. Food Chem 2011;126:1800–7.
29. Julious SA. Sample sizes for clinical trials with normal data. Stat Med 2004;23:1921–86.
30. Julious SA, Campbell MJ. Tutorial in biostatistics: sample sizes for parallel group clinical trials with binary data. Stat Med 2012;31:2904–36.
31. Jones B, Jarvis P, Lewis JA, Ebbutt AF. Trials to assess equivalence: the importance of rigorous methods. BMJ 1996;313:36–9.
32. Reinisch W, Staun M, Tandon RK, Altorjay I, Thillainayagam AV, Gratzer C, Nijhawan S, Thomsen LL. A randomized, open-label, noninferiority study of intravenous iron isomaltoside 1,000 (Monofer) compared with oral iron for treatment of anemia in IBD (PROCEED). Am J Gastroenterol 2013;108:1877–88.
33. Vanrenterghem Y, Bárány P, Mann JF, Kerr PG, Wilson J, Baker NF, Gray SJ; European/Australian NESP 970200 Study Group. Randomized trial of darbepoetin alfa for treatment of renal anemia at a reduced dose frequency compared with rHuEPO in dialysis patients. Kidney Int 2002;62:2167–75.
34. Lauritsen JM, Bruus M. EpiData entry version 3.02: a comprehensive tool for validated entry and documentation of data. 3.02 ed. Odense (Denmark): The EpiData Association; 2003.
35. StataCorp. Stata 13 statistical software. College Station (TX): StataCorp; 2013.
36. World Health Organization. Haemoglobin concentrations for the diagnosis of anemia and assessment of severity. Geneva (Switzerland): WHO; 2011.
37. Thurnham DI, McCabe LD, Haldar S, Wieringa FT, Northrop-Clewes CA, McCabe GP. Adjusting plasma ferritin concentrations to remove the effects of subclinical inflammation in the assessment of iron deficiency: a meta-analysis. Am J Clin Nutr 2010;92:546–55.
38. Cook RJ, Farewell VT. Multiplicity considerations in the design and analysis of clinical trials. J R Stat Soc Ser A 1996;159:93–110.
39. Bender R, Lange S. Adjusting for multiple testing—when and how? J Clin Epidemiol 2001;54:343–9.
40. Piaggio G, Elbourne DR, Altman DG, Pocock SJ, Evans SJ. Reporting of noninferiority and equivalence randomized trials: an extension of the CONSORT statement. JAMA 2006;295:1152–60.
41. Le Henanff A, Giraudeau B, Baron G, Ravaud P. Quality of reporting of noninferiority and equivalence randomized trials. JAMA 2006;295: 1147–51.
42. Mascha EJ, Sessler DI. Equivalence and noninferiority testing in regression models and repeated-measures designs. Anesth Analg 2011; 112:678–87.
43. Greenland S. Modeling and variable selection in epidemiologic analysis. Am J Public Health 1989;79:340–9.
44. Özkale M, Sipahi T. Hematologic and bone marrow changes in children with protein-energy malnutrition. Pediatr Hematol Oncol 2014; 31:349–58.
45. Nkrumah FK, Nathoo KJ, Sanders DM. Iron, folate and vitamin B12 in severe protein-energy malnutrition. Cent Afr J Med 1988;34:39–43.
46. Abbaspour N, Hurrell R, Kelishadi R. Review on iron and its importance for human health. J Res Med Sci 2014;19:164–74.
47. Hurrell RF, Lynch SR, Trinidad TP, Dassenko SA, Cook JD. Iron absorption in humans as influenced by bovine milk proteins. Am J Clin Nutr 1989;49:546–52.
48. Walczyk T, Muthayya S, Wegmuller R, Thankachan P, Sierksma A, Frenken LG, Thomas T, Kurpad A, Hurrell RF. Inhibition of iron absorption by calcium is modest in an iron-fortified, casein- and whey-based drink in Indian children and is easily compensated for by addition of ascorbic acid. J Nutr 2014;144:1703–9.
49. Uauy R, Suri DJ, Ghosh S, Kurpad A, Rosenberg IH. Low circulating amino acids and protein quality: an interesting piece in the puzzle of early childhood stunting. EBioMedicine 2016;8:28–9.
50. Suri DJ, Tano-Debrah K, Ghosh SA. Optimization of the nutrient content and protein quality of cereal-legume blends for use as complementary foods in Ghana. Food Nutr Bull 2014;35:372–81.
51. Yang Z. Are peanut allergies a concern for using peanut-based formulated foods in developing countries? Food Nutr Bull 2010;31(2 Suppl):S147–53.
52. Prescott SL, Pawankar R, Allen KJ, Campbell DE, Sinn JK, Fiocchi A, Ebisawa M, Sampson HA, Beyer K, Lee B-W. A global survey of changing patterns of food allergy burden in children. World Allergy Organ J 2013;6:21.
53. Weber JM, Ryan KN, Tandon R, Mathur M, Girma T, Steiner-Asiedu M, Saalia F, Zaidi S, Soofi S, Okos M, et al. Acceptability of locally produced ready-to-use therapeutic foods in Ethiopia, Ghana, Pakistan and India. Matern Child Nutr 2017;13:e12250.
54. Beesabathuni KN, Natchu UC. Production and distribution of a therapeutic nutritional product for severe acute malnutrition in India: opportunities and challenges. Indian Pediatr 2010;47:702–6.
55. Dube B, Rongsen T, Mazumder S, Taneja S, Rafiqui F, Bhandari N, Bhan MK. Comparison of ready-to-use therapeutic food with cereal legume-based khichri among malnourished children. Indian Pediatr 2009;46:383–8.
56. Khlangwiset P, Wu F. Costs and efficacy of public health interventions to reduce aflatoxin-induced human disease. Food Addit Contam Part A Chem Anal Control Expo Risk Assess 2010;27:998–1014.
57. Khlangwiset P, Shephard GS, Wu F. Aflatoxins and growth impairment: a review. Crit Rev Toxicol 2011;41:740–55.